Phospho-TAU (Thr181) cellular HTRF kit | Cisbio
Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer's disease | medRxiv
Plasma pTau181 as a biomarker for Alzheimer's disease - Meng - 2020 - MedComm - Wiley Online Library
IJMS | Free Full-Text | Protein Biomarkers for the Diagnosis of Alzheimer's Disease at Different Stages of Neurodegeneration
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study - The Lancet Neurology
![Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET - eBioMedicine](https://www.thelancet.com/cms/asset/40dffde0-5333-4ccf-9aee-5eca64f597b8/gr1.jpg "Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET - eBioMedicine")
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET - eBioMedicine
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected | EMBO Molecular Medicine
Association of plasma P-tau181 with CSF P-tau181 and Aβ PET (a)... | Download Scientific Diagram
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected | EMBO Molecular Medicine
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer's amyloid, tau and FDG PET status | Translational Psychiatry
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression | Alzheimer's Research & Therapy | Full Text
Earliest of Them All: Blood P-Tau231 Assay Flags Pre-Amyloid Alzheimer's | ALZFORUM
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology
Frontiers | Phosphorylated Tau 181 Serum Levels Predict Alzheimer's Disease in the Preclinical Stage
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration | Nature Medicine
Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals | medRxiv
Phospho-Tau (Thr181) Antibody | Cell Signaling Technology
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline | SpringerLink
Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition | Journal of Neurology, Neurosurgery & Psychiatry
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration | Nature Medicine
Associations of plasma p-tau181 baseline levels and longitudinal... | Download Scientific Diagram
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. - Abstract - Europe PMC
Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis - Karikari - 2021 - Alzheimer's & Dementia - Wiley Online Library
